Signal active
Bio
Martin Huber is the President of Xilio Therapeutics, Inc. He previously worked at TESARO as a Chief Medical Officer, SVP. Martin Huber attended Baylor College of Medicine.
Location
Butler, New Jersey, United States, North America
Social
Primary Organization
2016
51-100
Biotechnology, Health Care, Biopharma, Therapeutics, Oncology
Jobs history
4
Xilio Therapeutics
President
2022 - Current
Merck
VP Oncology
2012 - 2015
TESARO
Chief Medical Officer, SVP
2015 - 2020
Xilio Therapeutics
Chief Medical Officer
2020 - 2022
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Martin Huber is the President at Xilio Therapeutics, based in United States, North America. With a background in Biotechnology, Martin Huber has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.